Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI
- 15 June 1991
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 62 (6), 607-614
- https://doi.org/10.1016/0049-3848(91)90365-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulationThrombosis Research, 1991
- Release of extrinsic pathway inhibitor after heparin injection: Increased response in cancer patientsThrombosis Research, 1990
- Regulation of coagulation by a multivalent Kunitz-type inhibitorBiochemistry, 1990
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanismBlood, 1989
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of actionBlood, 1988
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987
- Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulationBlood, 1987
- A Comparison of two Heparin-Neutralizing Agents: Protamine and PolybreneScandinavian Journal of Clinical and Laboratory Investigation, 1960